Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$BDSI Tennessee is the largest Medicaid state for buprenorphine/naloxone treatment of opioid dependence. The recently signed contract between Tennessee Medicaid and BioDelivery Sciences came into effect on October 1, making Bunavail “the only preferred buprenorphine/ naloxone treatment for opioid dependence on the preferred drug list.”
http://yhoo.it/1G2RecP
I use Fidelity, if I call them I can sell my $AVXLD.
Yes it was. ;~)
weed time. LOL
Thanks. I'm watching it. Just got dry powder today.
$CPRX insiders buying, upcoming catalyst.http://bit.ly/1j2Mt94
Over 52% owned by institutions. Baker Bros holding over 7 mil shares. http://bit.ly/1j5gkhe
$CPRX always like insider buying before an upcoming catalyst.
$CPRX somebody bought a big block around noon. 42,655 shares @ 2.84.
Yeah been watching it. No dry powder today.
np kei.
$CPRX has catalysts coming up so to me it's a good time to buy.
http://bit.ly/1j2Mt94
Enough bozo. You're on ignore.
Almost even on the buying/selling scammer!
$MEIP This shows it.
http://bit.ly/1KJ5shJ
$MEIP
FRIGATE VENTURES LP 06/30/2015 283,749
283,749 New 457
http://bit.ly/1KPtgxo
Institutions hold 3.01%. Not a very large chunk. http://bit.ly/1P3Arbj
$RXII RXi Pharmaceuticals Granted Patent in China for Lead
Clinical Candidate RXI-109
MARLBOROUGH, Mass.
,
Sept. 28, 2015
/PRNewswire/
--
RXi Pharmaceuticals Corporation
(NASDAQ:
RXII
), a biotechnology
company focused on discovering and developing innovative
therapies primarily in the areas of dermatology and ophthalmology, today
announced that it has
been granted a patent from the State Intellectual Property Office of the People's Republic of China (SIP
O) for the composition and methods of use for RXI-109 and other connective tissue growth factor (CTGF) targeting self -
delivering RNAi compounds (sd-rxRNA®) for the treatment of
fibrotic disorders, including skin fibrosis. The patent is scheduled to expire in 2031.
http://investors.rxipharma.com/Cache/1500076361.PDF?Y=&O=PDF&D=&FID=1500076361&T=&IID=4418218
-
Thanks jembers. That's nice news.
What are the names of these other companies?
Thanks. Back at ya'.
I'm holding 44k shares, being patient.
I agree 100%. It's just the way it is when buying and selling stocks.
That pumping happens all over Ihub...................even on this board.
Ignore...................
$EDAP Do you have a link for this?
Ok. My apologies.
Yes I have. I've also seen frontloading and pumping and dumping. You can say a dog"s tail is a fifth leg and get some people to believe it but it is still just a tail. With that said I still hold some shares.
Sal the market is treating $GNSZ like it isn't undervalued.
$KBIO From their 10-Q PART II. OTHER INFORMATION
Item 1. Legal Proceedings
We are not currently a party to any material legal proceedings.
Item 1A. Risk Factors
Risk Related to Our Business and the Development, Regulatory Approval, and Commercialization of Our Product Candidates
We will need substantial additional capital to develop and commercialize our product candidates, and we may be unable to raise additional capital when needed, or at all, which would force us to reduce or discontinue operations.
As of June 30 , 2015, we had $ 23.0 million in cash, cash equivalents, and investments. We utilized $ 14.9 million of cash in operating activities during the six months ended June 3 0 , 2015. Additionally, in August 2015 under the Amendment No. Two to the Loan and Security A greement with MidCap Financial , we transferred an amount equal to the aggregate of the remaining future payments under the Loan and Security Agreement, equating to $8.3 million, in a segregated deposit account. While these funds will be used to make the MidCap loan payments as they become due, w e cannot use these funds for other business purposes , including the operations of our business. Therefore, a substantial amount of our cash cannot be used without the consent of MidCap Financial .
http://bit.ly/1NfTiQW
So you're the only one who isn't lazy and reads all these $TPIV filings? You are something else.......
Yes it is.............
$TNXP Mario bought another 10,000 sh @ 6.05
Join the herd crop.
Lot of people are hoping for a pop off Sprout's news on flibanserin.
Bremelanotide has fewer side effects.
$PTN I watched it on CNBC. They just went over what everybody knows about flibanserin already.
$PTN people are unsure because flibanserin has received a CRL twice.
$PTN Apparently a lot of people thought the same thing thus all the dumping on the news.
Old news.....